CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹800 Cr | ₹875 Cr | ₹1,565 Cr | ₹1,928 Cr | ₹1,401 Cr |
What is the latest Cash and Bank ratio of CIPLA ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹800 Cr |
| Mar2024 | ₹875 Cr |
| Mar2023 | ₹1,565 Cr |
| Mar2022 | ₹1,928 Cr |
| Mar2021 | ₹1,401 Cr |
How is Cash and Bank of CIPLA Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹800 Cr | -8.59 | |
| Mar2024 | ₹875 Cr | -44.08 | |
| Mar2023 | ₹1,565 Cr | -18.87 | |
| Mar2022 | ₹1,928 Cr | 37.63 | |
| Mar2021 | ₹1,401 Cr | - | |
Compare Cash and Bank of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹115,640.6 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
| MANKIND PHARMA | ₹103,368.0 Cr | 1.4% | 18% | -1.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 9.7% |
16.7% |
-4.9% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses